SocialMED

About SocialMED

SocialMED, registered as Shanghai Qingyun Pharmaceutical Technology Co., Ltd., operates as a specialized digital marketing services provider with a sharp focus on China's pharmaceutical and medical sectors. The company was established in Shanghai in 2017 by its founder, Yan Guowei (Luis Yan). Yan's journey into entrepreneurship was shaped by his unique career trajectory, which began with a clinical medicine degree and a position as a doctor at Shanghai Renji Hospital. He later transitioned to the commercial side of healthcare, gaining substantial experience in sales and marketing at major multinational pharmaceutical firms, including Pfizer and Roche, and serving as a senior vice president at E-Town Medical. This dual perspective, combining medical practice with pharmaceutical marketing, provided him with deep insights into the industry's inefficiencies. The turning point came with major policy shifts in China's healthcare landscape, which squeezed profit margins for traditional, representative-heavy sales models and created a clear opening for more efficient, technology-driven solutions.

SocialMED's business is centered on delivering integrated, multi-channel digital marketing solutions to pharmaceutical companies. Its cornerstone service is a "virtual representative" model, which utilizes technology to conduct remote academic promotion and engagement with healthcare professionals. This approach was designed to overcome the high costs and logistical challenges of reaching a vast and geographically dispersed network of doctors, particularly in grassroots and lower-tier markets. The platform leverages artificial intelligence and machine learning to analyze data and deliver highly relevant medical information to physicians at opportune moments, enhancing the effectiveness of this digital engagement. Revenue is generated by providing these comprehensive marketing solutions to pharmaceutical clients, helping them to improve brand reach and sales conversion rates across a product's lifecycle.

Over time, the company has evolved its model from a purely online approach to a sophisticated, omnichannel strategy that integrates its virtual representatives with offline sales teams, online doctor communities, and digital learning platforms. This hybrid model delivers a more holistic service, with the company even starting to offer sales-outcome-based results in county-level markets. A significant milestone in the company's history was the formation of a strategic partnership with IQVIA in 2019 to co-develop an AI-based digital marketing solution, combining SocialMED's operational model with IQVIA's data and analytics capabilities. The company has successfully raised capital across multiple funding rounds to fuel its expansion, with investors including notable firms like IDG Capital, Alibaba Health Information Technology, Long Hill Capital, and Kangjun Capital.